665 related articles for article (PubMed ID: 14695889)
21. Targeting HMGB1 in the treatment of sepsis.
Wang H; Ward MF; Sama AE
Expert Opin Ther Targets; 2014 Mar; 18(3):257-68. PubMed ID: 24392842
[TBL] [Abstract][Full Text] [Related]
22. Systemic and local high mobility group box 1 concentrations during severe infection.
van Zoelen MA; Laterre PF; van Veen SQ; van Till JW; Wittebole X; Bresser P; Tanck MW; Dugernier T; Ishizaka A; Boermeester MA; van der Poll T
Crit Care Med; 2007 Dec; 35(12):2799-804. PubMed ID: 17901841
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor 4 and high-mobility group box 1 are critical mediators of tissue injury and survival in a mouse model for heatstroke.
Dehbi M; Uzzaman T; Baturcam E; Eldali A; Ventura W; Bouchama A
PLoS One; 2012; 7(9):e44100. PubMed ID: 22962600
[TBL] [Abstract][Full Text] [Related]
24. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.
Pavlov VA; Ochani M; Yang LH; Gallowitsch-Puerta M; Ochani K; Lin X; Levi J; Parrish WR; Rosas-Ballina M; Czura CJ; Larosa GJ; Miller EJ; Tracey KJ; Al-Abed Y
Crit Care Med; 2007 Apr; 35(4):1139-44. PubMed ID: 17334244
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic potential of HMGB1-targeting agents in sepsis.
Wang H; Zhu S; Zhou R; Li W; Sama AE
Expert Rev Mol Med; 2008 Nov; 10():e32. PubMed ID: 18980707
[TBL] [Abstract][Full Text] [Related]
26. The gesture life of high mobility group box 1.
Friedman SG; Czura CJ; Tracey KJ
Curr Opin Clin Nutr Metab Care; 2003 May; 6(3):283-7. PubMed ID: 12690260
[TBL] [Abstract][Full Text] [Related]
27. Heparin inhibits the inflammatory response induced by LPS and HMGB1 by blocking the binding of HMGB1 to the surface of macrophages.
Li L; Ling Y; Huang M; Yin T; Gou SM; Zhan NY; Xiong JX; Wu HS; Yang ZY; Wang CY
Cytokine; 2015 Mar; 72(1):36-42. PubMed ID: 25562836
[TBL] [Abstract][Full Text] [Related]
28. Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1.
Leelahavanichkul A; Huang Y; Hu X; Zhou H; Tsuji T; Chen R; Kopp JB; Schnermann J; Yuen PS; Star RA
Kidney Int; 2011 Dec; 80(11):1198-211. PubMed ID: 21832986
[TBL] [Abstract][Full Text] [Related]
29. High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor.
Czura CJ; Yang H; Tracey KJ
J Infect Dis; 2003 Jun; 187 Suppl 2():S391-6. PubMed ID: 12792856
[TBL] [Abstract][Full Text] [Related]
30. Extracellular role of HMGB1 in inflammation and sepsis.
Wang H; Yang H; Tracey KJ
J Intern Med; 2004 Mar; 255(3):320-31. PubMed ID: 14871456
[TBL] [Abstract][Full Text] [Related]
31. [Reproduction of a model of "two-hit" sepsis model with complication of pneumonia in rat].
Chen Y; Li H; Ma S; Deng B; Lu J; Ding F
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Oct; 27(10):805-10. PubMed ID: 27132442
[TBL] [Abstract][Full Text] [Related]
32. Endogenous HMGB1 is required in endotoxin tolerance.
Li S; Luo C; Yin C; Peng C; Han R; Zhou J; He Q; Zhou J
J Surg Res; 2013 Nov; 185(1):319-28. PubMed ID: 23866790
[TBL] [Abstract][Full Text] [Related]
33. [Changing laws of serum high mobility group box 1 protein in septic rats and the intervention effect of xuebijing].
Zhao SB; He XD; Wang HX; Zheng SY; Deng XM; Duan LB
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jun; 34(6):739-44. PubMed ID: 25046960
[TBL] [Abstract][Full Text] [Related]
34. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
Tang Y; Lv B; Wang H; Xiao X; Zuo X
Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
[TBL] [Abstract][Full Text] [Related]
35. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
36. The protective effect of lidocaine on septic rats via the inhibition of high mobility group box 1 expression and NF-κB activation.
Wang HL; Xing YQ; Xu YX; Rong F; Lei WF; Zhang WH
Mediators Inflamm; 2013; 2013():570370. PubMed ID: 24371375
[TBL] [Abstract][Full Text] [Related]
37. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria.
Chorny A; Anderson P; Gonzalez-Rey E; Delgado M
J Immunol; 2008 Jun; 180(12):8369-77. PubMed ID: 18523304
[TBL] [Abstract][Full Text] [Related]
38. Baicalin inhibits high-mobility group box 1 release and improves survival in experimental sepsis.
Wang H; Liu D
Shock; 2014 Apr; 41(4):324-30. PubMed ID: 24430548
[TBL] [Abstract][Full Text] [Related]
39. Suppressive Effects of Ginsenoside Rh1 on HMGB1-Mediated Septic Responses.
Lee W; Cho SH; Kim JE; Lee C; Lee JH; Baek MC; Song GY; Bae JS
Am J Chin Med; 2019; 47(1):119-133. PubMed ID: 30630344
[TBL] [Abstract][Full Text] [Related]
40. Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.
Tamada K; Nakajima S; Ogawa N; Inada M; Shibasaki H; Sato A; Takasawa R; Yoshimori A; Suzuki Y; Watanabe N; Oyama T; Abe H; Inoue S; Abe T; Yokomizo T; Tanuma S
Biochem Biophys Res Commun; 2019 Apr; 511(3):665-670. PubMed ID: 30826057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
